L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
Aberrant beta-catenin-TCF target gene activation plays a key role in colorectal cancer, both in the initiation stage and during invasion and metastasis. We identified the neuronal cell adhesion molecule L1, as a target gene of beta-catenin-TCF signaling in colorectal cancer cells. L1 expression was high in sparse cultures and coregulated with ADAM10, a metalloprotease involved in cleaving and shedding L1's extracellular domain. L1 expression conferred increased cell motility, growth in low serum, transformation and tumorigenesis, whereas its suppression in colon cancer cells decreased motility. L1 was exclusively localized in the invasive front of human colorectal tumors together with ADAM10. The transmembrane localization and shedding of L1 by metalloproteases could be useful for detection and as target for colon cancer therapy.
Gavert
Nancy
N
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.
Conacci-Sorrell
Maralice
M
Gast
Daniela
D
Schneider
Annette
A
Altevogt
Peter
P
Brabletz
Thomas
T
Ben-Ze'ev
Avri
A
D051722:ADAM Proteins; D000072197:ADAM10 Protein; D053829:Amyloid Precursor Protein Secretases; D000818:Animals; D002465:Cell Movement / Q000235:genetics / Q000502:physiology*; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000235:genetics / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008565:Membrane Proteins; D008666:Metalloendopeptidases; D051379:Mice; D041681:NIH 3T3 Cells; D039842:Neural Cell Adhesion Molecule L1 / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic / Q000235:genetics; D034741:RNA, Small Interfering / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D015534:Trans-Activators / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D051176:beta Catenin
C495270:CTNNB1 protein, human; C495267:CTNNB1 protein, mouse; D003598:Cytoskeletal Proteins; D008565:Membrane Proteins; D039842:Neural Cell Adhesion Molecule L1; D034741:RNA, Small Interfering; D015534:Trans-Activators; D051176:beta Catenin; D053829:Amyloid Precursor Protein Secretases; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000072197:ADAM10 Protein; C491236:ADAM10 protein, human
Clin Exp Metastasis. 1993 Sep;11(5):419-29
8375117
Genomics. 1991 Oct;11(2):416-23
1769655
Science. 1997 Mar 21;275(5307):1787-90
9065402
J Cell Biol. 1997 Sep 22;138(6):1343-54
9298989
J Biol Chem. 1999 Dec 31;274(53):37965-73
10608864
Cancer Res. 2000 Mar 15;60(6):1552-6
10749122
Hum Mol Genet. 2000 Apr 12;9(6):879-86
10767310
Genes Dev. 2000 Aug 1;14(15):1837-51
10921899
Cell. 2000 Oct 13;103(2):311-20
11057903
J Surg Oncol. 2001 May;77(1):49-54
11344483
Cancer Res. 2001 Sep 1;61(17):6345-9
11522623
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10356-61
11526241
J Cell Biol. 2001 Nov 12;155(4):661-73
11706054
Cancer Res. 2001 Nov 15;61(22):8089-93
11719433
Trends Mol Med. 2001 Dec;7(12):535-7
11733201
Hum Mol Genet. 2002 Jan 1;11(1):1-12
11772994
Cancer Res. 1998 Apr 1;58(7):1344-7
9537226
J Cell Biol. 1998 Jun 15;141(6):1433-48
9628899
Science. 1998 Sep 4;281(5382):1509-12
9727977
Mol Cell Neurosci. 1998 Sep;12(1-2):48-55
9770339
Curr Opin Cell Biol. 1998 Oct;10(5):629-39
9818174
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15339-44
9860970
J Cell Biol. 1998 Dec 28;143(7):2067-79
9864376
Oncogene. 1999 Jan 21;18(3):813-22
9989833
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1603-8
9990071
Am J Pathol. 1999 Feb;154(2):515-23
10027409
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2420-5
10051657
Nature. 1999 Apr 1;398(6726):422-6
10201372
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
10318916
Oncogene. 1999 May 6;18(18):2883-91
10362259
Mol Cell Biol. 1999 Aug;19(8):5576-87
10409747
Am J Pathol. 1999 Oct;155(4):1033-8
10514384
Am J Med Genet. 2002 Feb 15;108(1):51-6
11857550
J Clin Invest. 2002 Apr;109(8):987-91
11956233
Eur J Cancer. 2002 Sep;38(13):1708-16
12175686
Genes Dev. 2002 Aug 15;16(16):2058-72
12183361
Oncogene. 2002 Aug 29;21(38):5861-7
12185585
Cell. 2002 Oct 18;111(2):241-50
12408868
Cell. 2002 Oct 18;111(2):251-63
12408869
Oncogene. 2002 Nov 14;21(52):7981-90
12439748
Nature. 2002 Nov 21;420(6913):274-5, 277
12447423
FASEB J. 2003 Feb;17(2):292-4
12475894
EMBO Rep. 2003 Jun;4(6):609-15
12776180
Cancer Cell. 2003 Jul;4(1):41-53
12892712
Lancet. 2003 Sep 13;362(9387):869-75
13678974
Int J Cancer. 2004 Jan 10;108(2):321-6
14639622
J Cell Biol. 2003 Nov 24;163(4):847-57
14623871
J Biol Chem. 2004 Jul 9;279(28):28880-8
15128735
EMBO J. 1987 Sep;6(9):2581-6
3315649
Cell. 1994 Jun 17;77(6):841-52
7911739